Global Pharmaceutical CXO Supply, Demand and Key Producers, 2023-2029

Description

The global Pharmaceutical CXO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.

In the process of new drug development, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies commission drug R&D and production companies to provide professional R&D services, including technical process development, API and CCMO production, formulation production, etc.

This report studies the global Pharmaceutical CXO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CXO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CXO that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pharmaceutical CXO total market, 2018-2029, (USD Million)
Global Pharmaceutical CXO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CXO total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CXO revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CXO total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CXO total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Pharmaceutical CXO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, AGC Biologics, Asym Chemical, Avid Bioservices, Boehringer Ingelheim, Catalent, Charles River Laboratories, Fareva and FUJIFILM Diosynth Biotechnologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CXO market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pharmaceutical CXO Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pharmaceutical CXO Market, Segmentation by Type
    CRO
    CMO
    CDMO

Global Pharmaceutical CXO Market, Segmentation by Application
    Pharmaceutical Company
    Biotechnology Company
    Others

Companies Profiled:
    AbbVie
    AGC Biologics
    Asym Chemical
    Avid Bioservices
    Boehringer Ingelheim
    Catalent
    Charles River Laboratories
    Fareva
    FUJIFILM Diosynth Biotechnologies
    GenScript
    IQVIA
    Jiuzhou Pharma
    Labcorp Drug Development
    Lonza Group AG
    MabPlex International
    Parexel
    Patheon
    Pfizer CentreOne
    Pharmablock
    Pharmaron Inc
    Samsung Biologics
    Shanghai ChemPartner
    Siegfried
    Syneos Health
    Thermo Fisher Scientific
    Tigermed
    WuXi AppTec
    Wuxi Biologics
    Delpharm
    Recipharm
    Vetter
    Curia
    Aenova
    Porton
    Piramal

Key Questions Answered
1. How big is the global Pharmaceutical CXO market?
2. What is the demand of the global Pharmaceutical CXO market?
3. What is the year over year growth of the global Pharmaceutical CXO market?
4. What is the total value of the global Pharmaceutical CXO market?
5. Who are the major players in the global Pharmaceutical CXO market?

Table of Contents

1 Supply Summary
    1.1 Pharmaceutical CXO Introduction
    1.2 World Pharmaceutical CXO Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Pharmaceutical CXO Total Market by Region (by Headquarter Location)
        1.3.1 World Pharmaceutical CXO Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Pharmaceutical CXO Market Size (2018-2029)
        1.3.3 China Pharmaceutical CXO Market Size (2018-2029)
        1.3.4 Europe Pharmaceutical CXO Market Size (2018-2029)
        1.3.5 Japan Pharmaceutical CXO Market Size (2018-2029)
        1.3.6 South Korea Pharmaceutical CXO Market Size (2018-2029)
        1.3.7 ASEAN Pharmaceutical CXO Market Size (2018-2029)
        1.3.8 India Pharmaceutical CXO Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pharmaceutical CXO Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pharmaceutical CXO Major Market Trends

2 Demand Summary
    2.1 World Pharmaceutical CXO Consumption Value (2018-2029)
    2.2 World Pharmaceutical CXO Consumption Value by Region
        2.2.1 World Pharmaceutical CXO Consumption Value by Region (2018-2023)
        2.2.2 World Pharmaceutical CXO Consumption Value Forecast by Region (2024-2029)
    2.3 United States Pharmaceutical CXO Consumption Value (2018-2029)
    2.4 China Pharmaceutical CXO Consumption Value (2018-2029)
    2.5 Europe Pharmaceutical CXO Consumption Value (2018-2029)
    2.6 Japan Pharmaceutical CXO Consumption Value (2018-2029)
    2.7 South Korea Pharmaceutical CXO Consumption Value (2018-2029)
    2.8 ASEAN Pharmaceutical CXO Consumption Value (2018-2029)
    2.9 India Pharmaceutical CXO Consumption Value (2018-2029)

3 World Pharmaceutical CXO Companies Competitive Analysis
    3.1 World Pharmaceutical CXO Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Pharmaceutical CXO Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CXO in 2022
        3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CXO in 2022
    3.3 Pharmaceutical CXO Company Evaluation Quadrant
    3.4 Pharmaceutical CXO Market: Overall Company Footprint Analysis
        3.4.1 Pharmaceutical CXO Market: Region Footprint
        3.4.2 Pharmaceutical CXO Market: Company Product Type Footprint
        3.4.3 Pharmaceutical CXO Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Pharmaceutical CXO Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Pharmaceutical CXO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Pharmaceutical CXO Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Pharmaceutical CXO Consumption Value Comparison
        4.2.1 United States VS China: Pharmaceutical CXO Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Pharmaceutical CXO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Pharmaceutical CXO Companies and Market Share, 2018-2023
        4.3.1 United States Based Pharmaceutical CXO Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Pharmaceutical CXO Revenue, (2018-2023)
    4.4 China Based Companies Pharmaceutical CXO Revenue and Market Share, 2018-2023
        4.4.1 China Based Pharmaceutical CXO Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Pharmaceutical CXO Revenue, (2018-2023)
    4.5 Rest of World Based Pharmaceutical CXO Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Pharmaceutical CXO Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Pharmaceutical CXO Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Pharmaceutical CXO Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 CRO
        5.2.2 CMO
        5.2.3 CDMO
    5.3 Market Segment by Type
        5.3.1 World Pharmaceutical CXO Market Size by Type (2018-2023)
        5.3.2 World Pharmaceutical CXO Market Size by Type (2024-2029)
        5.3.3 World Pharmaceutical CXO Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Pharmaceutical CXO Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical Company
        6.2.2 Biotechnology Company
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Pharmaceutical CXO Market Size by Application (2018-2023)
        6.3.2 World Pharmaceutical CXO Market Size by Application (2024-2029)
        6.3.3 World Pharmaceutical CXO Market Size by Application (2018-2029)

7 Company Profiles
    7.1 AbbVie
        7.1.1 AbbVie Details
        7.1.2 AbbVie Major Business
        7.1.3 AbbVie Pharmaceutical CXO Product and Services
        7.1.4 AbbVie Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 AbbVie Recent Developments/Updates
        7.1.6 AbbVie Competitive Strengths & Weaknesses
    7.2 AGC Biologics
        7.2.1 AGC Biologics Details
        7.2.2 AGC Biologics Major Business
        7.2.3 AGC Biologics Pharmaceutical CXO Product and Services
        7.2.4 AGC Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 AGC Biologics Recent Developments/Updates
        7.2.6 AGC Biologics Competitive Strengths & Weaknesses
    7.3 Asym Chemical
        7.3.1 Asym Chemical Details
        7.3.2 Asym Chemical Major Business
        7.3.3 Asym Chemical Pharmaceutical CXO Product and Services
        7.3.4 Asym Chemical Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Asym Chemical Recent Developments/Updates
        7.3.6 Asym Chemical Competitive Strengths & Weaknesses
    7.4 Avid Bioservices
        7.4.1 Avid Bioservices Details
        7.4.2 Avid Bioservices Major Business
        7.4.3 Avid Bioservices Pharmaceutical CXO Product and Services
        7.4.4 Avid Bioservices Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Avid Bioservices Recent Developments/Updates
        7.4.6 Avid Bioservices Competitive Strengths & Weaknesses
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Details
        7.5.2 Boehringer Ingelheim Major Business
        7.5.3 Boehringer Ingelheim Pharmaceutical CXO Product and Services
        7.5.4 Boehringer Ingelheim Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Boehringer Ingelheim Recent Developments/Updates
        7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.6 Catalent
        7.6.1 Catalent Details
        7.6.2 Catalent Major Business
        7.6.3 Catalent Pharmaceutical CXO Product and Services
        7.6.4 Catalent Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Catalent Recent Developments/Updates
        7.6.6 Catalent Competitive Strengths & Weaknesses
    7.7 Charles River Laboratories
        7.7.1 Charles River Laboratories Details
        7.7.2 Charles River Laboratories Major Business
        7.7.3 Charles River Laboratories Pharmaceutical CXO Product and Services
        7.7.4 Charles River Laboratories Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Charles River Laboratories Recent Developments/Updates
        7.7.6 Charles River Laboratories Competitive Strengths & Weaknesses
    7.8 Fareva
        7.8.1 Fareva Details
        7.8.2 Fareva Major Business
        7.8.3 Fareva Pharmaceutical CXO Product and Services
        7.8.4 Fareva Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Fareva Recent Developments/Updates
        7.8.6 Fareva Competitive Strengths & Weaknesses
    7.9 FUJIFILM Diosynth Biotechnologies
        7.9.1 FUJIFILM Diosynth Biotechnologies Details
        7.9.2 FUJIFILM Diosynth Biotechnologies Major Business
        7.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product and Services
        7.9.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
        7.9.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
    7.10 GenScript
        7.10.1 GenScript Details
        7.10.2 GenScript Major Business
        7.10.3 GenScript Pharmaceutical CXO Product and Services
        7.10.4 GenScript Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 GenScript Recent Developments/Updates
        7.10.6 GenScript Competitive Strengths & Weaknesses
    7.11 IQVIA
        7.11.1 IQVIA Details
        7.11.2 IQVIA Major Business
        7.11.3 IQVIA Pharmaceutical CXO Product and Services
        7.11.4 IQVIA Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 IQVIA Recent Developments/Updates
        7.11.6 IQVIA Competitive Strengths & Weaknesses
    7.12 Jiuzhou Pharma
        7.12.1 Jiuzhou Pharma Details
        7.12.2 Jiuzhou Pharma Major Business
        7.12.3 Jiuzhou Pharma Pharmaceutical CXO Product and Services
        7.12.4 Jiuzhou Pharma Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Jiuzhou Pharma Recent Developments/Updates
        7.12.6 Jiuzhou Pharma Competitive Strengths & Weaknesses
    7.13 Labcorp Drug Development
        7.13.1 Labcorp Drug Development Details
        7.13.2 Labcorp Drug Development Major Business
        7.13.3 Labcorp Drug Development Pharmaceutical CXO Product and Services
        7.13.4 Labcorp Drug Development Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Labcorp Drug Development Recent Developments/Updates
        7.13.6 Labcorp Drug Development Competitive Strengths & Weaknesses
    7.14 Lonza Group AG
        7.14.1 Lonza Group AG Details
        7.14.2 Lonza Group AG Major Business
        7.14.3 Lonza Group AG Pharmaceutical CXO Product and Services
        7.14.4 Lonza Group AG Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Lonza Group AG Recent Developments/Updates
        7.14.6 Lonza Group AG Competitive Strengths & Weaknesses
    7.15 MabPlex International
        7.15.1 MabPlex International Details
        7.15.2 MabPlex International Major Business
        7.15.3 MabPlex International Pharmaceutical CXO Product and Services
        7.15.4 MabPlex International Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 MabPlex International Recent Developments/Updates
        7.15.6 MabPlex International Competitive Strengths & Weaknesses
    7.16 Parexel
        7.16.1 Parexel Details
        7.16.2 Parexel Major Business
        7.16.3 Parexel Pharmaceutical CXO Product and Services
        7.16.4 Parexel Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Parexel Recent Developments/Updates
        7.16.6 Parexel Competitive Strengths & Weaknesses
    7.17 Patheon
        7.17.1 Patheon Details
        7.17.2 Patheon Major Business
        7.17.3 Patheon Pharmaceutical CXO Product and Services
        7.17.4 Patheon Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Patheon Recent Developments/Updates
        7.17.6 Patheon Competitive Strengths & Weaknesses
    7.18 Pfizer CentreOne
        7.18.1 Pfizer CentreOne Details
        7.18.2 Pfizer CentreOne Major Business
        7.18.3 Pfizer CentreOne Pharmaceutical CXO Product and Services
        7.18.4 Pfizer CentreOne Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Pfizer CentreOne Recent Developments/Updates
        7.18.6 Pfizer CentreOne Competitive Strengths & Weaknesses
    7.19 Pharmablock
        7.19.1 Pharmablock Details
        7.19.2 Pharmablock Major Business
        7.19.3 Pharmablock Pharmaceutical CXO Product and Services
        7.19.4 Pharmablock Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Pharmablock Recent Developments/Updates
        7.19.6 Pharmablock Competitive Strengths & Weaknesses
    7.20 Pharmaron Inc
        7.20.1 Pharmaron Inc Details
        7.20.2 Pharmaron Inc Major Business
        7.20.3 Pharmaron Inc Pharmaceutical CXO Product and Services
        7.20.4 Pharmaron Inc Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Pharmaron Inc Recent Developments/Updates
        7.20.6 Pharmaron Inc Competitive Strengths & Weaknesses
    7.21 Samsung Biologics
        7.21.1 Samsung Biologics Details
        7.21.2 Samsung Biologics Major Business
        7.21.3 Samsung Biologics Pharmaceutical CXO Product and Services
        7.21.4 Samsung Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.21.5 Samsung Biologics Recent Developments/Updates
        7.21.6 Samsung Biologics Competitive Strengths & Weaknesses
    7.22 Shanghai ChemPartner
        7.22.1 Shanghai ChemPartner Details
        7.22.2 Shanghai ChemPartner Major Business
        7.22.3 Shanghai ChemPartner Pharmaceutical CXO Product and Services
        7.22.4 Shanghai ChemPartner Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.22.5 Shanghai ChemPartner Recent Developments/Updates
        7.22.6 Shanghai ChemPartner Competitive Strengths & Weaknesses
    7.23 Siegfried
        7.23.1 Siegfried Details
        7.23.2 Siegfried Major Business
        7.23.3 Siegfried Pharmaceutical CXO Product and Services
        7.23.4 Siegfried Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.23.5 Siegfried Recent Developments/Updates
        7.23.6 Siegfried Competitive Strengths & Weaknesses
    7.24 Syneos Health
        7.24.1 Syneos Health Details
        7.24.2 Syneos Health Major Business
        7.24.3 Syneos Health Pharmaceutical CXO Product and Services
        7.24.4 Syneos Health Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.24.5 Syneos Health Recent Developments/Updates
        7.24.6 Syneos Health Competitive Strengths & Weaknesses
    7.25 Thermo Fisher Scientific
        7.25.1 Thermo Fisher Scientific Details
        7.25.2 Thermo Fisher Scientific Major Business
        7.25.3 Thermo Fisher Scientific Pharmaceutical CXO Product and Services
        7.25.4 Thermo Fisher Scientific Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.25.5 Thermo Fisher Scientific Recent Developments/Updates
        7.25.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.26 Tigermed
        7.26.1 Tigermed Details
        7.26.2 Tigermed Major Business
        7.26.3 Tigermed Pharmaceutical CXO Product and Services
        7.26.4 Tigermed Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.26.5 Tigermed Recent Developments/Updates
        7.26.6 Tigermed Competitive Strengths & Weaknesses
    7.27 WuXi AppTec
        7.27.1 WuXi AppTec Details
        7.27.2 WuXi AppTec Major Business
        7.27.3 WuXi AppTec Pharmaceutical CXO Product and Services
        7.27.4 WuXi AppTec Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.27.5 WuXi AppTec Recent Developments/Updates
        7.27.6 WuXi AppTec Competitive Strengths & Weaknesses
    7.28 Wuxi Biologics
        7.28.1 Wuxi Biologics Details
        7.28.2 Wuxi Biologics Major Business
        7.28.3 Wuxi Biologics Pharmaceutical CXO Product and Services
        7.28.4 Wuxi Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.28.5 Wuxi Biologics Recent Developments/Updates
        7.28.6 Wuxi Biologics Competitive Strengths & Weaknesses
    7.29 Delpharm
        7.29.1 Delpharm Details
        7.29.2 Delpharm Major Business
        7.29.3 Delpharm Pharmaceutical CXO Product and Services
        7.29.4 Delpharm Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.29.5 Delpharm Recent Developments/Updates
        7.29.6 Delpharm Competitive Strengths & Weaknesses
    7.30 Recipharm
        7.30.1 Recipharm Details
        7.30.2 Recipharm Major Business
        7.30.3 Recipharm Pharmaceutical CXO Product and Services
        7.30.4 Recipharm Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.30.5 Recipharm Recent Developments/Updates
        7.30.6 Recipharm Competitive Strengths & Weaknesses
    7.31 Vetter
        7.31.1 Vetter Details
        7.31.2 Vetter Major Business
        7.31.3 Vetter Pharmaceutical CXO Product and Services
        7.31.4 Vetter Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.31.5 Vetter Recent Developments/Updates
        7.31.6 Vetter Competitive Strengths & Weaknesses
    7.32 Curia
        7.32.1 Curia Details
        7.32.2 Curia Major Business
        7.32.3 Curia Pharmaceutical CXO Product and Services
        7.32.4 Curia Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.32.5 Curia Recent Developments/Updates
        7.32.6 Curia Competitive Strengths & Weaknesses
    7.33 Aenova
        7.33.1 Aenova Details
        7.33.2 Aenova Major Business
        7.33.3 Aenova Pharmaceutical CXO Product and Services
        7.33.4 Aenova Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.33.5 Aenova Recent Developments/Updates
        7.33.6 Aenova Competitive Strengths & Weaknesses
    7.34 Porton
        7.34.1 Porton Details
        7.34.2 Porton Major Business
        7.34.3 Porton Pharmaceutical CXO Product and Services
        7.34.4 Porton Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.34.5 Porton Recent Developments/Updates
        7.34.6 Porton Competitive Strengths & Weaknesses
    7.35 Piramal
        7.35.1 Piramal Details
        7.35.2 Piramal Major Business
        7.35.3 Piramal Pharmaceutical CXO Product and Services
        7.35.4 Piramal Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023)
        7.35.5 Piramal Recent Developments/Updates
        7.35.6 Piramal Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pharmaceutical CXO Industry Chain
    8.2 Pharmaceutical CXO Upstream Analysis
    8.3 Pharmaceutical CXO Midstream Analysis
    8.4 Pharmaceutical CXO Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pharmaceutical CXO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Pharmaceutical CXO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Pharmaceutical CXO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Pharmaceutical CXO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Pharmaceutical CXO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Pharmaceutical CXO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Pharmaceutical CXO Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Pharmaceutical CXO Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Pharmaceutical CXO Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Pharmaceutical CXO Players in 2022
    Table 12. World Pharmaceutical CXO Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Pharmaceutical CXO Company Evaluation Quadrant
    Table 14. Head Office of Key Pharmaceutical CXO Player
    Table 15. Pharmaceutical CXO Market: Company Product Type Footprint
    Table 16. Pharmaceutical CXO Market: Company Product Application Footprint
    Table 17. Pharmaceutical CXO Mergers & Acquisitions Activity
    Table 18. United States VS China Pharmaceutical CXO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Pharmaceutical CXO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Pharmaceutical CXO Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Pharmaceutical CXO Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Pharmaceutical CXO Revenue Market Share (2018-2023)
    Table 23. China Based Pharmaceutical CXO Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Pharmaceutical CXO Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Pharmaceutical CXO Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Pharmaceutical CXO Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Pharmaceutical CXO Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Pharmaceutical CXO Revenue Market Share (2018-2023)
    Table 29. World Pharmaceutical CXO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Pharmaceutical CXO Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Pharmaceutical CXO Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Pharmaceutical CXO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Pharmaceutical CXO Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Pharmaceutical CXO Market Size by Application (2024-2029) & (USD Million)
    Table 35. AbbVie Basic Information, Area Served and Competitors
    Table 36. AbbVie Major Business
    Table 37. AbbVie Pharmaceutical CXO Product and Services
    Table 38. AbbVie Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. AbbVie Recent Developments/Updates
    Table 40. AbbVie Competitive Strengths & Weaknesses
    Table 41. AGC Biologics Basic Information, Area Served and Competitors
    Table 42. AGC Biologics Major Business
    Table 43. AGC Biologics Pharmaceutical CXO Product and Services
    Table 44. AGC Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. AGC Biologics Recent Developments/Updates
    Table 46. AGC Biologics Competitive Strengths & Weaknesses
    Table 47. Asym Chemical Basic Information, Area Served and Competitors
    Table 48. Asym Chemical Major Business
    Table 49. Asym Chemical Pharmaceutical CXO Product and Services
    Table 50. Asym Chemical Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Asym Chemical Recent Developments/Updates
    Table 52. Asym Chemical Competitive Strengths & Weaknesses
    Table 53. Avid Bioservices Basic Information, Area Served and Competitors
    Table 54. Avid Bioservices Major Business
    Table 55. Avid Bioservices Pharmaceutical CXO Product and Services
    Table 56. Avid Bioservices Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Avid Bioservices Recent Developments/Updates
    Table 58. Avid Bioservices Competitive Strengths & Weaknesses
    Table 59. Boehringer Ingelheim Basic Information, Area Served and Competitors
    Table 60. Boehringer Ingelheim Major Business
    Table 61. Boehringer Ingelheim Pharmaceutical CXO Product and Services
    Table 62. Boehringer Ingelheim Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Boehringer Ingelheim Recent Developments/Updates
    Table 64. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 65. Catalent Basic Information, Area Served and Competitors
    Table 66. Catalent Major Business
    Table 67. Catalent Pharmaceutical CXO Product and Services
    Table 68. Catalent Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Catalent Recent Developments/Updates
    Table 70. Catalent Competitive Strengths & Weaknesses
    Table 71. Charles River Laboratories Basic Information, Area Served and Competitors
    Table 72. Charles River Laboratories Major Business
    Table 73. Charles River Laboratories Pharmaceutical CXO Product and Services
    Table 74. Charles River Laboratories Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Charles River Laboratories Recent Developments/Updates
    Table 76. Charles River Laboratories Competitive Strengths & Weaknesses
    Table 77. Fareva Basic Information, Area Served and Competitors
    Table 78. Fareva Major Business
    Table 79. Fareva Pharmaceutical CXO Product and Services
    Table 80. Fareva Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Fareva Recent Developments/Updates
    Table 82. Fareva Competitive Strengths & Weaknesses
    Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
    Table 84. FUJIFILM Diosynth Biotechnologies Major Business
    Table 85. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product and Services
    Table 86. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
    Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
    Table 89. GenScript Basic Information, Area Served and Competitors
    Table 90. GenScript Major Business
    Table 91. GenScript Pharmaceutical CXO Product and Services
    Table 92. GenScript Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. GenScript Recent Developments/Updates
    Table 94. GenScript Competitive Strengths & Weaknesses
    Table 95. IQVIA Basic Information, Area Served and Competitors
    Table 96. IQVIA Major Business
    Table 97. IQVIA Pharmaceutical CXO Product and Services
    Table 98. IQVIA Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. IQVIA Recent Developments/Updates
    Table 100. IQVIA Competitive Strengths & Weaknesses
    Table 101. Jiuzhou Pharma Basic Information, Area Served and Competitors
    Table 102. Jiuzhou Pharma Major Business
    Table 103. Jiuzhou Pharma Pharmaceutical CXO Product and Services
    Table 104. Jiuzhou Pharma Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Jiuzhou Pharma Recent Developments/Updates
    Table 106. Jiuzhou Pharma Competitive Strengths & Weaknesses
    Table 107. Labcorp Drug Development Basic Information, Area Served and Competitors
    Table 108. Labcorp Drug Development Major Business
    Table 109. Labcorp Drug Development Pharmaceutical CXO Product and Services
    Table 110. Labcorp Drug Development Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Labcorp Drug Development Recent Developments/Updates
    Table 112. Labcorp Drug Development Competitive Strengths & Weaknesses
    Table 113. Lonza Group AG Basic Information, Area Served and Competitors
    Table 114. Lonza Group AG Major Business
    Table 115. Lonza Group AG Pharmaceutical CXO Product and Services
    Table 116. Lonza Group AG Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Lonza Group AG Recent Developments/Updates
    Table 118. Lonza Group AG Competitive Strengths & Weaknesses
    Table 119. MabPlex International Basic Information, Area Served and Competitors
    Table 120. MabPlex International Major Business
    Table 121. MabPlex International Pharmaceutical CXO Product and Services
    Table 122. MabPlex International Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. MabPlex International Recent Developments/Updates
    Table 124. MabPlex International Competitive Strengths & Weaknesses
    Table 125. Parexel Basic Information, Area Served and Competitors
    Table 126. Parexel Major Business
    Table 127. Parexel Pharmaceutical CXO Product and Services
    Table 128. Parexel Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Parexel Recent Developments/Updates
    Table 130. Parexel Competitive Strengths & Weaknesses
    Table 131. Patheon Basic Information, Area Served and Competitors
    Table 132. Patheon Major Business
    Table 133. Patheon Pharmaceutical CXO Product and Services
    Table 134. Patheon Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Patheon Recent Developments/Updates
    Table 136. Patheon Competitive Strengths & Weaknesses
    Table 137. Pfizer CentreOne Basic Information, Area Served and Competitors
    Table 138. Pfizer CentreOne Major Business
    Table 139. Pfizer CentreOne Pharmaceutical CXO Product and Services
    Table 140. Pfizer CentreOne Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Pfizer CentreOne Recent Developments/Updates
    Table 142. Pfizer CentreOne Competitive Strengths & Weaknesses
    Table 143. Pharmablock Basic Information, Area Served and Competitors
    Table 144. Pharmablock Major Business
    Table 145. Pharmablock Pharmaceutical CXO Product and Services
    Table 146. Pharmablock Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Pharmablock Recent Developments/Updates
    Table 148. Pharmablock Competitive Strengths & Weaknesses
    Table 149. Pharmaron Inc Basic Information, Area Served and Competitors
    Table 150. Pharmaron Inc Major Business
    Table 151. Pharmaron Inc Pharmaceutical CXO Product and Services
    Table 152. Pharmaron Inc Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 153. Pharmaron Inc Recent Developments/Updates
    Table 154. Pharmaron Inc Competitive Strengths & Weaknesses
    Table 155. Samsung Biologics Basic Information, Area Served and Competitors
    Table 156. Samsung Biologics Major Business
    Table 157. Samsung Biologics Pharmaceutical CXO Product and Services
    Table 158. Samsung Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 159. Samsung Biologics Recent Developments/Updates
    Table 160. Samsung Biologics Competitive Strengths & Weaknesses
    Table 161. Shanghai ChemPartner Basic Information, Area Served and Competitors
    Table 162. Shanghai ChemPartner Major Business
    Table 163. Shanghai ChemPartner Pharmaceutical CXO Product and Services
    Table 164. Shanghai ChemPartner Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 165. Shanghai ChemPartner Recent Developments/Updates
    Table 166. Shanghai ChemPartner Competitive Strengths & Weaknesses
    Table 167. Siegfried Basic Information, Area Served and Competitors
    Table 168. Siegfried Major Business
    Table 169. Siegfried Pharmaceutical CXO Product and Services
    Table 170. Siegfried Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 171. Siegfried Recent Developments/Updates
    Table 172. Siegfried Competitive Strengths & Weaknesses
    Table 173. Syneos Health Basic Information, Area Served and Competitors
    Table 174. Syneos Health Major Business
    Table 175. Syneos Health Pharmaceutical CXO Product and Services
    Table 176. Syneos Health Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 177. Syneos Health Recent Developments/Updates
    Table 178. Syneos Health Competitive Strengths & Weaknesses
    Table 179. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 180. Thermo Fisher Scientific Major Business
    Table 181. Thermo Fisher Scientific Pharmaceutical CXO Product and Services
    Table 182. Thermo Fisher Scientific Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 183. Thermo Fisher Scientific Recent Developments/Updates
    Table 184. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 185. Tigermed Basic Information, Area Served and Competitors
    Table 186. Tigermed Major Business
    Table 187. Tigermed Pharmaceutical CXO Product and Services
    Table 188. Tigermed Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 189. Tigermed Recent Developments/Updates
    Table 190. Tigermed Competitive Strengths & Weaknesses
    Table 191. WuXi AppTec Basic Information, Area Served and Competitors
    Table 192. WuXi AppTec Major Business
    Table 193. WuXi AppTec Pharmaceutical CXO Product and Services
    Table 194. WuXi AppTec Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 195. WuXi AppTec Recent Developments/Updates
    Table 196. WuXi AppTec Competitive Strengths & Weaknesses
    Table 197. Wuxi Biologics Basic Information, Area Served and Competitors
    Table 198. Wuxi Biologics Major Business
    Table 199. Wuxi Biologics Pharmaceutical CXO Product and Services
    Table 200. Wuxi Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 201. Wuxi Biologics Recent Developments/Updates
    Table 202. Wuxi Biologics Competitive Strengths & Weaknesses
    Table 203. Delpharm Basic Information, Area Served and Competitors
    Table 204. DelpharmMajor Business
    Table 205. Delpharm Pharmaceutical CXO Product and Services
    Table 206. Delpharm Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 207. Delpharm Recent Developments/Updates
    Table 208. Delpharm Competitive Strengths & Weaknesses
    Table 209. Recipharm Basic Information, Area Served and Competitors
    Table 210. Recipharm Major Business
    Table 211. Recipharm Pharmaceutical CXO Product and Services
    Table 212. Recipharm Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 213. Recipharm Recent Developments/Updates
    Table 214. Recipharm Competitive Strengths & Weaknesses
    Table 215. Vetter Basic Information, Area Served and Competitors
    Table 216. Vetter Major Business
    Table 217. Vetter Pharmaceutical CXO Product and Services
    Table 218. Vetter Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 219. Vetter Recent Developments/Updates
    Table 220. Vetter Competitive Strengths & Weaknesses
    Table 221. Curia Basic Information, Area Served and Competitors
    Table 222. Curia Major Business
    Table 223. Curia Pharmaceutical CXO Product and Services
    Table 224. Curia Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 225. Curia Recent Developments/Updates
    Table 226. Curia Competitive Strengths & Weaknesses
    Table 227. Aenova Basic Information, Area Served and Competitors
    Table 228. Aenova Major Business
    Table 229. Aenova Pharmaceutical CXO Product and Services
    Table 230. Aenova Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 231. Aenova Recent Developments/Updates
    Table 232. Aenova Competitive Strengths & Weaknesses
    Table 233. Porton Basic Information, Area Served and Competitors
    Table 234. Porton Major Business
    Table 235. Porton Pharmaceutical CXO Product and Services
    Table 236. Porton Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 237. Porton Recent Developments/Updates
    Table 238. Piramal Basic Information, Area Served and Competitors
    Table 239. Piramal Major Business
    Table 240. Piramal Pharmaceutical CXO Product and Services
    Table 241. Piramal Pharmaceutical CXO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 242. Global Key Players of Pharmaceutical CXO Upstream (Raw Materials)
    Table 243. Pharmaceutical CXO Typical Customers
List of Figure
    Figure 1. Pharmaceutical CXO Picture
    Figure 2. World Pharmaceutical CXO Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Pharmaceutical CXO Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Pharmaceutical CXO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Pharmaceutical CXO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Pharmaceutical CXO Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Pharmaceutical CXO Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Pharmaceutical CXO Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Pharmaceutical CXO Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Pharmaceutical CXO Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Pharmaceutical CXO Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Pharmaceutical CXO Revenue (2018-2029) & (USD Million)
    Figure 13. Pharmaceutical CXO Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Pharmaceutical CXO Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Pharmaceutical CXO Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Pharmaceutical CXO by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical CXO Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical CXO Markets in 2022
    Figure 27. United States VS China: Pharmaceutical CXO Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Pharmaceutical CXO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Pharmaceutical CXO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Pharmaceutical CXO Market Size Market Share by Type in 2022
    Figure 31. CRO
    Figure 32. CMO
    Figure 33. CDMO
    Figure 34. World Pharmaceutical CXO Market Size Market Share by Type (2018-2029)
    Figure 35. World Pharmaceutical CXO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Pharmaceutical CXO Market Size Market Share by Application in 2022
    Figure 37. Pharmaceutical Company
    Figure 38. Biotechnology Company
    Figure 39. Others
    Figure 40. Pharmaceutical CXO Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

AbbVie
AGC Biologics
Asym Chemical
Avid Bioservices
Boehringer Ingelheim
Catalent
Charles River Laboratories
Fareva
FUJIFILM Diosynth Biotechnologies
GenScript
IQVIA
Jiuzhou Pharma
Labcorp Drug Development
Lonza Group AG
MabPlex International
Parexel
Patheon
Pfizer CentreOne
Pharmablock
Pharmaron Inc
Samsung Biologics
Shanghai ChemPartner
Siegfried
Syneos Health
Thermo Fisher Scientific
Tigermed
WuXi AppTec
Wuxi Biologics
Delpharm
Recipharm
Vetter
Curia
Aenova
Porton
Piramal